Antibodies Market Analysis and Reports | USA Conference Series

Market Analysis - Antibodies-2017

Monoclonal antibodies (Antibody drugs) are now used for treatment of a wide array of diseases, especially cancer, autoimmune, and inflammatory diseases. The development of these new molecular agents, successfully directed to specific cellular targets, is expected to play an increasingly important role in future clinical protocol, and perhaps finally provide a means to achieve long-term tolerance in human allograft recipients.

Large scale research development is being conducted in the field of antibody drugs for the past two decades. By 2009, approximately 30 new antibody drugs were launched in the market. With an intention of launching new blockbuster drugs and to reform the pharmaceuticals industry, large pharmaceutical companies have begun to undertake aggressive steps to enter this market. Hence, it is expected that the antibody drugs segment will experience impressive growth in the global pharmaceuticals market. For instance, the global market for therapeutic monoclonal antibodies (mAbs) was estimated at US$44.6 billion in 2011. The global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016 and is predicted to have a double digit growth of around 15% from the year 2012 to 2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Monoclonal Antibodies market has also been witnessing the trend of the increasing use of monoclonal antibodies in the development of personalized medicinesTechnological enhancements and huge R&D in genomic studies have propelled the growth of this market.

Globally, North America is viewed as the largest market for antibody drugs followed by Europe. However, infrastructural development in the healthcare system and growth in awareness regarding the treatment of chronic diseases may influence a rapid growth of this market in Asia and in other parts of the world.

Conferences Series invites all the participants from all over the world to attend “3rd Antibodies and Bio Therapeutics Congress” during November 08-09, 2017 in Las vegas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Antibodies-2017 which aims to gather the most elegant societies and industries along with the renowned and honorable persons form top universities across the globe. Antibodies-2017 on behalf of its organizing Committee welcomes all the Immunology researchers, industrialists, young scientists as well as student and corporate delegates to participate and to have a great experience. The theme of the conference of Antibodies is based on “Global Update on Antibodies, Bio Therapeutics: Research, Development and Market”. During Antibodies conferences, the International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Immunology and Microbiology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in tools and techniques. Conferences Series organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.